Suppr超能文献

人多能脂肪干细胞的低血清和无血清培养

Low serum and serum-free culture of multipotential human adipose stem cells.

作者信息

Parker A M, Shang H, Khurgel M, Katz A J

机构信息

Department of Plastic Surgery, University of Virginia, Charlottesville, VA 22908, USA.

出版信息

Cytotherapy. 2007;9(7):637-46. doi: 10.1080/14653240701508452.

Abstract

BACKGROUND

Adipose tissue provides an easily accessible and abundant source of putative stem cells for translational clinical research. Currently prevalent culture techniques include the use of FBS, a highly variable and undefined component, which brings with it the potential for adverse patient reactions. In an effort to eliminate the use of animal products in human adipose stem cell (ASC) cultures, we have developed two new culture methods, a very low human serum expansion medium and a completely serum-free medium.

METHODS

Through serial testing, a highly enriched medium formulation was developed for use with and without the addition of 0.5% human serum, an amount easily obtainable from autologous blood draws.

RESULTS

Very low-serum culture yielded population-doubling times averaging 1.86 days in early passage, while the serum-free formulation was associated with less robust cell growth, with doubling times averaging 5.79 days. ASC in both conditions maintained its ability to differentiate into adipo-, chondro- and osteogenic lineages in vitro, despite lower expression of CD34 in early passage. Expression of ALDH, HLA, CD133, CD184, and CD31 was comparable with that seen in cells cultured in 10% FBS.

DISCUSSION

These newly developed culture conditions provide a unique environment within which to study ASCs without the interference of animal serum, and allow for the rapid expansion of autologous ASCs in culture in an animal product-free environment for use in human clinical trials.

摘要

背景

脂肪组织为转化临床研究提供了一种易于获取且丰富的假定干细胞来源。目前普遍使用的培养技术包括使用胎牛血清(FBS),这是一种高度可变且成分不明确的物质,可能会给患者带来不良反应。为了在人脂肪干细胞(ASC)培养中消除动物产品的使用,我们开发了两种新的培养方法,一种是极低人血清扩增培养基,另一种是完全无血清培养基。

方法

通过系列测试,开发了一种高度富集的培养基配方,可在添加和不添加0.5%人血清的情况下使用,该血清量可轻松从自体抽血中获得。

结果

极低血清培养在早期传代时群体倍增时间平均为1.86天,而无血清配方的细胞生长则较弱,倍增时间平均为5.79天。两种条件下的ASC在体外均保持了向脂肪、软骨和成骨谱系分化的能力,尽管早期传代时CD34表达较低。醛脱氢酶(ALDH)、人类白细胞抗原(HLA)、CD133、CD184和CD31的表达与在10%FBS中培养的细胞相当。

讨论

这些新开发的培养条件提供了一个独特的环境,可在无动物血清干扰的情况下研究ASC,并允许在无动物产品的环境中在培养物中快速扩增自体ASC,用于人类临床试验。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验